Delcath Systems to Present at the H.C. Wainwright BioConnect Virtual Investor Conference on January 10, 2022
07.01.2022 - NEW YORK, Jan. 07, 2022 (GLOBE NEWSWIRE) - Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will participate in an upcoming virtual ...
Source: wallstreet-online.de